PubRank

Michael Glikson

Author PubWeight™ 66.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol 2008 2.87
2 The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol 2010 2.56
3 Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005 2.29
4 Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. J Am Coll Cardiol 2012 2.13
5 Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation 2006 2.11
6 Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls. Heart Rhythm 2004 1.86
7 The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J Am Coll Cardiol 2007 1.69
8 Left atrial contractile function following a successful modified Maze procedure at surgery and the risk for subsequent thromboembolic stroke. J Am Coll Cardiol 2011 1.62
9 A novel mutation in the HCN4 gene causes symptomatic sinus bradycardia in Moroccan Jews. J Cardiovasc Electrophysiol 2010 1.60
10 Pacemakers and magnetic resonance imaging: no longer an absolute contraindication when scanned correctly. Isr Med Assoc J 2010 1.59
11 Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia. Circulation 2007 1.55
12 Effect of bundle branch block patterns on mortality in hospitalized patients with heart failure. Am J Cardiol 2008 1.53
13 Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator. Heart Rhythm 2010 1.47
14 Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene. Heart Rhythm 2011 1.46
15 Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System. Am J Cardiol 2011 1.45
16 Electrophysiological testing and ablation in an asymptomatic child with Wolff-Parkinson-White syndrome. Isr Med Assoc J 2010 1.41
17 Functional response to cardiac resynchronization therapy in patients with renal dysfunction and subsequent long-term mortality. J Cardiovasc Electrophysiol 2014 1.41
18 Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias. J Cardiovasc Electrophysiol 2008 1.40
19 Tilt training: does it have a role in preventing vasovagal syncope? Pacing Clin Electrophysiol 2007 1.38
20 EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace 2010 1.25
21 Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing Clin Electrophysiol 2005 1.23
22 Inhibition of biventricular pacemakers by oversensing of far-field atrial depolarization. Pacing Clin Electrophysiol 2002 1.07
23 Guidelines for treating cardiac manifestations of organophosphates poisoning with special emphasis on long QT and Torsades De Pointes. Crit Rev Toxicol 2007 1.02
24 Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU). Isr Med Assoc J 2008 0.97
25 Noncontact mapping to guide ablation of right ventricular outflow tract tachycardia. J Am Coll Cardiol 2002 0.96
26 Pericarditis following permanent pacemaker insertion. Isr Med Assoc J 2004 0.95
27 Randomized comparison of J-shaped atrial leads with and without active fixation mechanism. Pacing Clin Electrophysiol 2007 0.92
28 EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. EuroIntervention 2015 0.92
29 Relation of bundle branch block to long-term (four-year) mortality in hospitalized patients with systolic heart failure. Am J Cardiol 2010 0.92
30 Apical ballooning syndrome: a complication of dual chamber pacemaker implantation. Indian Pacing Electrophysiol J 2009 0.91
31 The Contribution of HCN4 to normal sinus node function in humans and animal models. Pacing Clin Electrophysiol 2009 0.90
32 The effect of electronic repositioning on left ventricular pacing and phrenic nerve stimulation. Europace 2011 0.88
33 Mechanism of diastolic mitral regurgitation in candidates for cardiac resynchronization therapy. Am J Cardiol 2006 0.88
34 Use of automatic threshold tracking function with non-low polarization leads: risk for algorithm malfunction. Pacing Clin Electrophysiol 2004 0.87
35 Use of advanced mapping systems to guide ablation in complex cases: experience with noncontact mapping and electroanatomic mapping systems. Pacing Clin Electrophysiol 2005 0.86
36 Incidence of dual AV node physiology following termination of AV nodal reentrant tachycardia by adenosine-5'-triphosphate: a comparison with drug administration in sinus rhythm. Indian Pacing Electrophysiol J 2003 0.86
37 Clinical characteristics of unexpected death among young enlisted military personnel: results of a three-decade retrospective surveillance. Chest 2004 0.84
38 Syncope Unit: rationale and requirement - the European Heart Rhythm Association position statement endorsed by the Heart Rhythm Society. Europace 2015 0.84
39 Right precordial lead (V4R) ST-segment elevation is associated with worse prognosis in patients with acute anterior myocardial infarction. J Am Coll Cardiol 2011 0.82
40 Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population. Europace 2013 0.81
41 The effects of anodal stimulation on electrocardiogram, left ventricular dyssynchrony, and acute haemodynamics in patients with biventricular pacemakers. Europace 2011 0.81
42 Mid-term results of the 'hybrid maze': a combination of bipolar radiofrequency and cryoablation for surgical treatment of atrial fibrillation. J Heart Valve Dis 2006 0.81
43 Comparison of results with different left ventricular pacing leads. Europace 2007 0.80
44 ST-segment deviation following implantable cardioverter defibrillator shocks: incidence, timing, and clinical significance. Pacing Clin Electrophysiol 2002 0.80
45 A family with recurrent sudden death and no clinical clue. Ann Noninvasive Electrocardiol 2012 0.79
46 Adaptive cardiac resynchronization therapy device: a simulation report. Pacing Clin Electrophysiol 2005 0.79
47 Atrial fibrillation in dobutamine stress echocardiography. Int J Cardiol 2005 0.78
48 LQT5 masquerading as LQT2: a dominant negative effect of KCNE1-D85N rare polymorphism on KCNH2 current. Europace 2011 0.78
49 Pre-admission NT-proBNP improves diagnostic yield and risk stratification - the NT-proBNP for EValuation of dyspnoeic patients in the Emergency Room and hospital (BNP4EVER) study. Eur Heart J Acute Cardiovasc Care 2012 0.78
50 The rationale and design of the Shockless IMPLant Evaluation (SIMPLE) trial: a randomized, controlled trial of defibrillation testing at the time of defibrillator implantation. Am Heart J 2012 0.78
51 Long-term prognosis of inducible ventricular flutter: not an innocent finding. Am Heart J 2004 0.78
52 Morphological features of the P-waves at surface electrocardiogram as surrogate to mechanical function of the left atrium following a successful modified maze procedure. Europace 2013 0.77
53 Efficacy of surgical ablation of atrial fibrillation in patients with rheumatic heart disease. Ann Thorac Surg 2010 0.77
54 Is flecainide dangerous in long QT-3 patients? Pacing Clin Electrophysiol 2009 0.77
55 Exercise heart rate acceleration patterns during atrial fibrillation and sinus rhythm. Ann Noninvasive Electrocardiol 2011 0.77
56 Long-term performance of screw-in atrial pacing leads: a randomized comparison of J-shaped and straight leads. Pacing Clin Electrophysiol 2005 0.77
57 Cardiac resynchronization therapy: a new frontier in the management of heart failure. Isr Med Assoc J 2003 0.77
58 Design and analysis issues in cardiac arrhythmia trials: insights from the Detect Supraventricular Tachycardia Trial. Clin Trials 2007 0.77
59 Improvement of congestive heart failure by upgrading of conventional to resynchronization pacemakers. Pacing Clin Electrophysiol 2006 0.76
60 Renal dysfunction and clinical outcomes of patients undergoing ICD and CRTD implantation: data from the Israeli ICD registry. J Cardiovasc Electrophysiol 2014 0.76
61 Effects of tricuspid valve regurgitation on clinical and echocardiographic outcome in patients with cardiac resynchronization therapy. Europace 2012 0.76
62 Multipole analysis of heart rate variability as a predictor of imminent ventricular arrhythmias in ICD patients. Pacing Clin Electrophysiol 2013 0.76
63 Plowing the atrium and growing thrombi: two cases of large atrial thrombi following ablative and surgical procedure for atrial fibrillation. Eur J Echocardiogr 2005 0.76
64 A novel form of familial bidirectional ventricular tachycardia. Am J Cardiol 2004 0.75
65 Conservative treatment of pacemaker pocket infection: is it a viable option? Europace 2012 0.75
66 Genetics and Sinus Node Dysfunction. J Atr Fibrillation 2009 0.75
67 The choice of an atrial lead--to each his/her own. Pacing Clin Electrophysiol 2011 0.75
68 Capture management in high-power devices: an important step forward or a new gadget? Europace 2010 0.75
69 Left atrial ablation for atrial fibrillation: creating the "box lesion" with a bipolar radiofrequency device. Tex Heart Inst J 2011 0.75
70 Adaptive cardiac resynchronization therapy device based on spiking neurons architecture and reinforcement learning scheme. IEEE Trans Neural Netw 2007 0.75
71 A nerve-racking syncope. Isr Med Assoc J 2002 0.75
72 Inappropriate Shocks and Power Delivery Using Adult Automatic External Defibrillator Pads in a Pediatric Patient. Pediatr Emerg Care 2017 0.75
73 Renin-angiotensin system inhibitors and atrial fibrillation. Isr Med Assoc J 2005 0.75
74 Clinical surveillance of a tined, bipolar, silicone-insulated ventricular pacing lead. Europace 2006 0.75
75 Use of adenosine test for the exclusion of preexcitation syndrome in asymptomatic individuals. Ann Noninvasive Electrocardiol 2011 0.75
76 Printed MDCT 3D models for prediction of left atrial appendage (LAA) occluder device size: a feasibility study. EuroIntervention 2017 0.75
77 [Cardiac MRI: report on preliminary experience in Sheba Medical Center and review of main indications]. Harefuah 2006 0.75
78 Clinical Outcomes in Patients with Severe Renal Dysfunction Including Dialysis Following Defibrillator Implantation. Am J Nephrol 2015 0.75
79 Multiple pulse generator malfunctions with a dual chamber pacemaker. Pacing Clin Electrophysiol 2002 0.75
80 Non-classical indications for cardiac resynchronization therapy. Hellenic J Cardiol 2009 0.75
81 [Bipolar radiofrequency and cryoablation for surgical treatment of atrial fibrillation]. Harefuah 2007 0.75
82 Beneficial effect of Bradycardia Tachycardia Response (BTR) algorithm on VT detection in the presence of rate smoothing. Pacing Clin Electrophysiol 2012 0.75
83 Tricuspid Regurgitation following Lead Extraction: Risk Factors and Clinical Course. Isr Med Assoc J 2016 0.75
84 Managing pacemaker safety alerts: experience with three successive models of a single manufacturer. Pacing Clin Electrophysiol 2003 0.75
85 Permanent pacemaker insertion following isolated aortic valve replacement before and after the introduction of TAVI. Pacing Clin Electrophysiol 2015 0.75
86 Discrepancies between the upper limit of vulnerability and defibrillation threshold: prevalence and clinical predictors. J Cardiovasc Electrophysiol 2003 0.75
87 Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic. Isr Med Assoc J 2014 0.75